Biotechnology Market Projected To Reach USD 3,879.51 Billion By 2030


 San Francisco, 10 Aug 2022: The Report Biotechnology Market Size, Share & Trends Analysis By Technology (DNA Sequencing, Fermentation), By Application (Health, Bioinformatics), By Region (North America, EU, APAC), And Segment Forecasts, 2022 - 2030

The global biotechnology market size is expected to reach USD 3,879.51 billion by 2030, registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors including the advent of innovative and advanced technologies, significant investments & government initiatives favoring the biotechnology industry, and rising demand for synthetic biology applications. Biotechnology startups are acquiring robust funding support and venture capital investments, which, in 2021, amounted to USD 41 billion; an increase of over 11% as compared to the previous year’s USD 36.7 billion. Notable funding rounds included Caris Life Sciences’ $830 million in May 2021 for its precision medicine platform expansion, Abogen’s $700 million Series C funding in August 2021 for its COVID-19 vaccine candidate’s clinical development, & ElevateBio’s $525 million Series C funding in March 2021 for advancing its cell & gene therapy technologies.

In addition, 28 new biotech unicorns were created in 2021, leading to a total of 192 unicorns present in the sector. Government support for the development of biotechnological infrastructure is also contributing to market growth. For instance, India’s Union Budget 2021-22 consisted of a provision of USD 227.94 million for biotechnology R&D, along with plans for the setting up of nine biosafety level-3 laboratories in the country. Furthermore, initiatives, such as Illumina Accelerator, are providing access to seed investment, genomics expertise, and Illumina sequencing systems & reagents to selected emerging companies and propelling the market growth.

Due to the COVID-19 pandemic, novel solutions are being explored in the development of vaccines & diagnostic tools for combating the disease. For instance, the advent of mRNA vaccines was supported by cutting-edge technologies in the biotechnology sector, including molecular research tools & genetic sequencing methods that accelerated the timelines for vaccine development. Furthermore, in March 2022, the Diagnostic Analyzer for Specific Hybridization (DASH), a highly sensitive and easy-to-perform PCR test for COVID-19, received FDA emergency use authorization. The test is commercialized by Minute Molecular Diagnostics and can deliver results within 15 minutes. Such advancements in molecular diagnostics are expected to fuel market growth.

Access Research Report of Biotechnology Market @ https://www.grandviewresearch.com/industry-analysis/biotechnology-market

Biotechnology Market Report Highlights

  • The health application segment accounted for the largest share in 2021 due to high disease prevalence, increasing focus on regenerative medicines, innovations in technologies fueled by the COVID-19 pandemic, and improvements in healthcare infrastructure
  • The DNA sequencing technology segment accounted for the second-largest share in 2021 as a result of declining costs of sequencing and its increasing adoption in precision medicine development
  • North America held the largest share of the global market in 2021 owing to the launch of advanced biotechnological solutions facilitated by key players operating in the region
  • Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 due to promising government initiatives and favorable regulatory changes in drug approval processes in India and China

List of Key Players in Biotechnology Market

  • AstraZeneca
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb
  • Sanofi
  • Biogen
  • Abbott Laboratories
  • Pfizer, Inc.
  • Amgen, Inc.
  • Novo Nordisk A/S
  • Merck KGaA
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Hoffmann-La Roche Ltd.
  • Lonza

Access Press Release of Biotechnology Market @ https://www.grandviewresearch.com/press-release/global-biotechnology-market

 

Comments

Post a Comment

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028

Image
  San Francisco, 21 Jan 2022:   The Report  U.K. Point Of Sale Software Market  Size, Share & Trends Analysis Report By Application (Fixed POS, Mobile POS), By Deployment, By Organization Size, By End-user, And Segment Forecasts, 2021 - 2028 The global U.K. point of sale software market size is expected to reach USD 1.05 billion by 2028, expanding at a CAGR of 8.1% from 2021 to 2028, according to the new study conducted by Grand View Research, Inc. The integration of a Point-Of-Sale (POS) solution with capabilities such as sales reports monitoring, cash flow recording, product demand analysis, tracking delivery status, and inventory management ensure systematic functioning and upscaling of a business. The adoption of POS software is directly impacted by the demand for POS terminals, which is witnessing growth in demand due to changing lifestyles and government policies. However, the COVID-19 pandemic disrupted the industry's business, wherein retail stores, restaurants, and hot
Read more